(UroToday.com) As part of a round table discussion on the impact of the COVID-19 epidemic on the management of GU cancers, Dr. Saskia Biskup discussed the impact of the coronavirus on the immune status of oncology patients. Dr. Biskup notes that precision medicine in cancer patients revolves around therapy adjustment, interdisciplinary tumor boards, and precision diagnostics. […]
(UroToday.com) In an oral presentation in the Refining the Treatment of Bladder Cancer session at the 12th European Multidisciplinary Congress on Urological Cancers (EMUC), Dr. Marc-Oliver Grimm presented an update on treatment options for patients with high-risk non-muscle-invasive bladder cancer. He began by emphasizing that this disease state is characterized by a high risk of recurrence […]
Cell entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) depends on binding of the viral spike (S) proteins to angiotensin-converting enzyme 2 and on S protein priming by TMPRSS2. Inhibition of TMPRSS2 may work to block or decrease the severity of SARS-CoV-2 infections.
(UroToday.com) Chairman of the European Association of Urology (EAU) Research Foundation, Dr. Anders Bjartell, provided an update of Trials in Progress as part of the Highlights in Genitourinary (GU) Cancers session at the European Multidisciplinary Congress on Urological Cancers (EMUC) 2020 virtual meeting. The goal of the EAU Research Foundation is to stimulate, facilitate, and conduct clinical […]
(UroToday.com) As part of the Highlights of Genitourinary (GU) Cancers session at the European Multidisciplinary Congress on Urological Cancers (EMUC) 2020 virtual meeting, Pathologist, Dr. Johnathan Epstein provided highlights from the Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer.1
(UroToday.com) The individualized approach in advanced prostate cancer session at the European Multidisciplinary Congress on Urological Cancers 2020 virtual meeting highlighted radiation oncologist, Dr. Piet Ost, discussing the optimal candidate for the treatment of the primary tumor in oligometastatic disease.
Active surveillance should be considered the first treatment for prostate cancer in order to ensure the best quality of life. This was one of the key messages of Mr. André Deschamps’ (BE) presentation during the “Highlights in GU cancers” session on the first day of the 12th European Multidisciplinary Congress on Urological Cancers (EMUC20 Virtual). Mr. […]
(UroToday.com) During the Individualized Approach in Advanced Prostate Cancer session at the European Multidisciplinary Congress on Urological Cancers (EMUC) 2020 virtual meeting, Dr. Declan Murphy presents on using prostate-specific membrane antigen (PSMA) positron emission tomography (PET) for upfront staging in high-risk prostate cancer disease. Dr. Murphy states that PSMA PET/CT is an obvious challenger to […]
(UroToday.com) The individualized approach in advanced prostate cancer session at the European Multidisciplinary Congress on Urological Cancers 2020 virtual meeting highlighted Dr. Declan Murphy discussing PSMA PET for upfront staging in high-risk disease. Dr. Murphy states that PSMA PET/CT is an obvious challenger to conventional imaging.
(UroToday.com) At the European Multidisciplinary Congress on Urological Cancers 2020 virtual meeting, the individualized approach in advanced prostate cancer session featured a presentation by Dr. Gerhardt Attard discussing when and how to germline and mutation test patients.
